Clinical Trials Directory

Trials / Completed

CompletedNCT01532375

Kochujang, a Fermented Soybean-based Red Pepper Paste, Decreases Visceral Fat and Improves Blood Lipid Profiles in Overweight Adults

Kochujang Decreases Visceral Fat and Improves Lipids Profiles

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Chonbuk National University Hospital · Academic / Other
Sex
All
Age
19 Years – 65 Years
Healthy volunteers
Accepted

Summary

With the epidemic of obesity and diabetes growing around the world, Kochujang (KCJ) may be potentially effective in preventing and treating obesity and cardiovascular risks if proven in humans. However, human trial still have not been reported with KCJ supplementation. In the present study, we investigated the hypothesis that KCJ supplementation can be decrease the body fat and improve blood lipid profiles in overweight adults.

Detailed description

The aim of this study was to evaluate the efficacy of KCJ supplementation on anthropometric parameters, visceral fat/subcutaneous fat, and blood lipid profiles in overweight subjects. Sixty overweight subjects with BMI \>25 kg/m2 and waist-hip-ratio (WHR) ≥ 0.90 for men and ≥ 0.85 for women were randomly assigned to either KCJ supplement (n=30, 32 g/day) or placebo (n=30, 32 g/day) group for 12 weeks.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTKochujangKochujang (32g/day) for 12weeks.
DIETARY_SUPPLEMENTplaceboplacebo(32g/day) for 12weeks

Timeline

Start date
2009-10-01
Primary completion
2010-03-01
Completion
2010-03-01
First posted
2012-02-14
Last updated
2012-02-14

Source: ClinicalTrials.gov record NCT01532375. Inclusion in this directory is not an endorsement.